NCT02633111 2025-11-04
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Memorial Sloan Kettering Cancer Center
Active not recruiting
Clinical Trials
9 trialsNCT04468841 2025-08-19
Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT04566978 2025-04-23
89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Completed
NCT04121507 2023-05-24
ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy
GWT-TUD GmbH
Phase 2 Completed
NCT03429387 2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA Completed
NCT02488369 2019-06-18
TEP-LYMPHOME
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Completed
NCT03564704 2018-06-21
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
Nanfang Hospital, Southern Medical University
Phase 2/3 Unknown
NCT02733887 2016-04-12
MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma
Guangxi Medical University
Phase NA Unknown
NCT00588328 2015-12-24
The Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment Planning
Memorial Sloan Kettering Cancer Center
Phase 1 Completed